Quantification of the eGFP to mCherry ratio following Her2 downregulation revealed progressive enrichment for eGFP-expressing Paqr8-OE cells across multiple stages of tumor progression, eventually resulting in recurrent tumors with > 90% Paqr8-OE cells (Fig. 3B). This evidence concerns the gene ERBB2 and neoplasm.